chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No appetite; couldn't open my eyes; high fever (102.8); Bad headache; tired; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), SOMNOLENCE (couldn't open my eyes), PYREXIA (high fever (102.8)), HEADACHE (Bad headache) and FATIGUE (tired) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (No appetite), SOMNOLENCE (couldn't open my eyes), PYREXIA (high fever (102.8)), HEADACHE (Bad headache), FATIGUE (tired), NAUSEA (nausea) and VOMITING (vomiting). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Fever, at a dose of 1 dosage form. At the time of the report, DECREASED APPETITE (No appetite), SOMNOLENCE (couldn't open my eyes), HEADACHE (Bad headache), FATIGUE (tired), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown and PYREXIA (high fever (102.8)) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102.8 (High) High, 102 (High) High and 100.1 (High) High.         No concomitant medications were given by the reporter.   This case was linked to MOD-2021-378646 (Patient Link).
Ringing in ear, mostly left ear. Pressure in both ears. Sometimes  enough that it hurts Like a low dull pain, ache steady  throughout day  The ring is usually lower too but on left ear is more piercing periodically.
Soreness in the left underarm, maybe soreness in lymphnode; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 07Mar2021 at 18:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (sulfa allergy) and fruit (avocado) allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medication within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took pertussis vaccine (MANUFACTURER UNKNOWN) on an unknown date and experienced vaccine allergy. On 10Mar2021 at 09:00, the patient experienced soreness in the left underarm, maybe soreness in the lymph node. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event soreness in the left underarm may be soreness in the lymph node was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported nerve pain, headache, tiredness, and weakness. Reported symptoms to patient's primary care doctor, via voicemail message at office.
states later that day of the vaccine, had a knot to area.  area is now red, warm to touch, sore   Advised to take Benadryl for the reaction
Started as severe pain in upper left shoulder. Loss of range of motion, cannot lift, pull with arm. Have trouble sleeping at night waking up with arm pain. Cannot do normal activities without pain. Very bothersome.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2010, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In July 2011, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the her injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earning capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Between 1st and 2nd dose of Pfizer covid vaccine, patient had a sports physical done for school. At that time she her BP and pulse were elevated. She presented to her PCP on 6/16/2021, 6 days after her 2nd dose, with a pulse of 172 bpm. After resting for several minutes it was still 180 bpm and again measured at 184 bpm. Her blood pressure was normal at 116/76. She was referred to the emergency department for further evaluation.
Migraines on 4/26/2021 followed by numbness/paresthesia on left cheek, eye, forehead and tongue. Some decreased hearing as well.
I got my period when I should not have. I was on Day 12 of my cycle, which is very regular, and got my period again for the second time in two weeks. I started spotting the morning after getting ym vaccine and was bleeding heavily by the next day. My period lasted five full days and was heavy on each day.   When I received my second shot I also got my period right away, however, this was 28 days after the first shot so it as not as alarming.
Developed fever next day then 3 days later developed sore throat - was seen in an Urgent Care - negative for strep. Two days later had difficulty breathing and expired in the ED of a large retropharyngeal abscess occluding airway - grew strep anginosus.
Patient had swelling that spread, area was also red, it became swollen all across arm Dx w/bacterial infection.
This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), GAIT INABILITY (could not stand up), PYREXIA (fever) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweating), GAIT INABILITY (could not stand up), PYREXIA (fever) and HEADACHE (headache). At the time of the report, HYPERHIDROSIS (sweating), GAIT INABILITY (could not stand up), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
On 1/30/02, mother brought child to health center where vaccination given. Complained of child having high fever and listless. Directed to local emergency room. Repeated calls and messages left at home next two weeks without response
Caller is experiencing some pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 20Sep2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset 20Sep2021, outcome "unknown", described as "Caller is experiencing some pain".  Additional information: Patient wanted know if she can take Tylenol, because she spoke with her healthcare provider, but would like to know if there are other pain medications, she can take as well.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a healthcare worker refers to unknown number of patients of unknown age. The unknown number of patients had received ZOSTAVAX (lot number not provided) and VARIVAX (merck) (lot number not provided) doses which were exposed to -6.8C for 1.5 hours every 24 hours due to defrost cycle every day. No adverse effect reported. It was unspecified if the patients had sought medical attention. The health care professional contacted during telephone follow-up did not remember which patient might have received these vaccines and could not supply the following information: patient name, date of birth, dates of vaccination, or lot number. She also stated that the vaccines had been moved to a proper storage unit. Follow-up information received from the healthcare worker. Patient information was updated. On 08-AUG-2013 the patient was vaccinated with a dose of improperly stored ZOSTAVAX (lot#, expiration date and route not reported). Additional information has been requested.
Originally went to ER, they diagnosed it as torticollis.  They sent me to my PCP who confirmed it.  I had violent & severe neck pain and severe headaches. Also an extremely stiff neck where I couldn?t turn it 1/8th oh an inch to either side.  It all got so severe that I didn?t eat for days at a time and was literally not with it.  Couldn?t respond when spoken to, and became excessively weak where I couldn?t walk w/o help, and speech was slurred.  It all lasted 5 days where it was so severe.  With medication it slowly began to back off.
a little sore arm; felt very very tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little sore arm) and FATIGUE (felt very very tired) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 003A21) for COVID-19 vaccination.     The patient's past medical history included Asthma, Stroke (Two times), Rheumatic fever (when patient was 5 year old) and Diverticulosis. Concomitant products included POTASSIUM and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication, CLOPIDOGREL BISULFATE (PLAVIX).   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (a little sore arm) and FATIGUE (felt very very tired). At the time of the report, PAIN IN EXTREMITY (a little sore arm) and FATIGUE (felt very very tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Action taken with mRNA-123 is not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-060848 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060848:Dose 2
swelling at the injection site; Patient felt wiped out the next day but not as bad as the first Moderna Covid-19 vaccine booster dose; Pain; pain at injection site; Redness at the injection site; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first Moderna Covid-19 vaccine booster dose), PAIN (Pain), INJECTION SITE PAIN (pain at injection site), INJECTION SITE ERYTHEMA (Redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) in a 68-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) (batch no. A17144B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Sep-2022, the patient received fifth dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. On 14-Sep-2022, the patient experienced FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first Moderna Covid-19 vaccine booster dose), PAIN (Pain), INJECTION SITE PAIN (pain at injection site) and INJECTION SITE ERYTHEMA (Redness at the injection site). On an unknown date, the patient experienced INJECTION SITE SWELLING (swelling at the injection site). At the time of the report, FEELING ABNORMAL (Patient felt wiped out the next day but not as bad as the first Moderna Covid-19 vaccine booster dose), PAIN (Pain), INJECTION SITE PAIN (pain at injection site), INJECTION SITE ERYTHEMA (Redness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) outcome was unknown.            No concomitant medication was reported.  No treatment information was reported.   This case was linked to MOD-2023-748680, MOD-2023-748684 (Patient Link).
Hospitalized for COVID-19 pneumonia on 4/23, ICU on 5/3, passed on 5/17 of 2021
This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  An elderly female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "PT caught COVID after vaccine".  Additional information:  Okay. And you probably know now that they want three. They recommend not just a second, now they're recommending a third. So, people with MS should definitely get that, and even though  you've already had COVID once, it doesn't mean you can't have it again.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Drug ineffective depends on many factors including pharmacokinetics, severity of disease and patient general health condition. However on conservative basis, the possible causality cannot be excluded.
COVID-19 diagnose after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 diagnose after vaccination) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure fluctuation. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN D NOS for an unknown indication, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP).   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced COVID-19 (COVID-19 diagnose after vaccination). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19 diagnose after vaccination) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, SARS-CoV-2 test positive: positive (Positive) Positive.         Treatment includes Apure.   Reporter did not allow further contact
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 13-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.  Treatment information was not provided. It was reported that the patient took the vaccine on 13Sep2021 after 6 days from first puncture.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow up received on 29 Sep 2021 contains no new information.
This spontaneous report was received from a physician referring to a patient of unknown age reported as: ("Age appropriate") and gender. The patient's concurrent conditions included diabetes mellitus and allergy to penicillin. On 09-MAY-2017, the patient was vaccinated with a dose of PNEUMOVAX 23 subcutaneously, lot # M033086, expiration date on 05-MAY-2018 (strength, dose number and anatomical location were not provided) for prophylaxis. Concomitant therapies included metformin and JANUVIA. On an unknown date, the patient experienced swelling, induration, redness in large part of deltoid. Physician stated that the patient had not received treatment for reaction. The case did not involve cancer or overdose. At the time of the report, the outcome of induration, peripheral swelling and erythema was reported as not recovered. The reporter did not assess the relatedness between induration, peripheral swelling and erythema and PNEUMOVAX 23. Additional information has been requested.
Myalgia; Feeling a little tired; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Myalgia) and FATIGUE (Feeling a little tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jun-2021, the patient experienced MYALGIA (Myalgia) and FATIGUE (Feeling a little tired). At the time of the report, MYALGIA (Myalgia) and FATIGUE (Feeling a little tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The concomitant medications were not reported.  The treatment information was not reported.
I had a lot of dizziness, heart palpitations thought it was heart condition although I never got chest pains.  At the end of the night I was still chest pain and pain down my entire left arm(felt as if it radiated from my chest to my arm), high heart rate regardless of standing or sitting. I went to the hospital had a EKG due to the compacity of patients I was sent home . Since discharged I have taken Ibuprofen.
This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 27-JUL-2018 the patient was vaccinated with an expired dose of PNEUMOVAX 23 lot # M039060 with expiration date: 22-MAY-2018 (dose was not reported), intramuscularly for prophylaxis (expired product administered). No adverse effects reported. This is one of the two cases received from the same reporter.; Sender's Comments: US-009507513-1808USA008371:
9/20/16 pt received MenB (BEXSERO) dose 2, within 2 hours came back to the office screaming that her "head was exploding" and that her "muscles were contracting". Gave her 800mg ibuprofen and 325mg TYLENOL and she turned around within 2 hrs. Very alarming appearance though.
Immunization administered 09/20/2005 Tuesday. Parent stated right leg erythema onset 09/21/2005. Pt reported to clinic on 09/22/2005. Sent to ER on 9/24/2005.
Stroke. Paralethis of one side of body.  Not treated immediatly due to age. ER visit when moved to assisted living.
No adverse event; 9 year old patient was accidentally administered the second dose of GARDASIL 9 intended for another patient; This spontaneous report was received from an administrator, referring to a 9-year-old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions/allergy were not reported.  On 19-MAY-2022, the wrong patient was administered a "booster dose" of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). The patient was accidentally administered the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) formulation prefilled syringe, 0.5 milliliter, lot #U035286, expiration date: 21-OCT-2023, administered for prophylaxis (strength, and route of administration were not provided), which intended for another patient (wrong patient received product). The patient who received the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) did not have any prior vaccination history with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). No additional adverse event reported.
Was awaken by a strange sensation that was not painful, but disturbing and it seemed to be in some of my nerves. I called my doctor's office, and the doctor on call said I should get it checkout. The ER doctor said the tests and blood work came back normal. The doctor said it was just a reaction to the vaccine. From time to time I still have that sensation, but not strong as at first. Also I had COVID symptoms the day after the injection, extreme tiredness, joint and back pain, foggy brain and cough.
Itchy rash, pain at injection site - 4 inches long, 2 inches wide
c/o rash, red, raised, burning on arms, legs & trunk started 48hr p/flu vax;dx systemic urticaria w/pruritis, no resp compromise;rx DPH, calamine lotion, corticosteroid cream;
Lite nausea and tired the next day; Lite nausea and tired the next day; This is a spontaneous report from a contactable consumer.  An 82-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), dose 1 via an unspecified route of administration in right arm on 29Jan2021 01:45 PM. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and was not on other medications. The patient was not diagnosed with COVID-19, prior to vaccination. On 29Jan2021 at 7:00 pm, the patient experienced Lite nausea and tired the next day. The patient has not been tested for COVID-19 Since the vaccination. There was no treatment received for adverse events. The outcome of events was recovered.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.